Revised SPC: OPDIVO (nivolumab) 10 mg/mL concentrate for solution for infusion

SPC revised with license extension to include use in the treatment of adult patients with unresectable advanced, recurrent or metastatic oesophageal squamous cell carcinoma after prior fluoropyrimidine- and platinum-based combination chemotherapy.

Source:

electronic Medicines compendium